BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) a medical technology company specializing in ...

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company ...

JAZZ™ PF: a simple, innovative and proprietary addition to the JAZZ® range Addressable annual market of almost $350 million in the United States1 IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, ...

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company ...

BORDEAUX, France & BOSTON, April 14, 2025--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, éligible PEA-PME), a medical technology company specializing in implants ...

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, ...

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants ...

Please provide your email address to receive an email when new articles are posted on . Implanet recently announced it has obtained a CE mark for its new JAZZ Standalone implant, a posterior fusion ...

The Spine Implants business generated revenue of €2.11 million in Q1 2025, reflecting an 8% increase compared to the €1.96 million recorded in Q1 2024. The Company also continued to expand its medical ...

Please provide your email address to receive an email when new articles are posted on . Implanet, a medical technology company specializing in vertebral and knee-surgery implants, recently announced ...